Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Sales Representative, Applied Biosystems

Academy for a new turn at work

Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...

Kol fortsätter att förbrylla

Trots många års forskning vet forskarna inte vilka mekanismer som ligger bakom sjukdomen kronisk obstruktiv lungsjukdom, kol. Det gör att det förväntas dröja in...

Enjoy Stockholm - the capital of Scandinavia

Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...

Ideon - Sweden's oldest science park

Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...

Algoritmer i stället för provrör

Mitt i Stockholm city jobbar drygt 70 personer med att ta fram och förfina mjukvaran till dosplaneringssystemet Raystation för strålterapi mot cancer.

Så vill politikerna vinna life science

Unik kartläggning visar: Så vill Alliansen och Socialdemokraterna vinna life science-branschen.

Bioarctic designar studien efterhand

Regelbunden utvärdering ger forskningsbolaget snabbare svar på effekt.

Biolamina tar täten när stamcellsfältet öppnas

En ny metod gör det möjligt att odla storskaliga mängder med embryonala stamceller utan att embryot förstörs. Metoden kan ge runt 400 kilo stamceller på en måna...

Utan Big Pharma stannar Sverige

De globala läkemedelsjättarna som har säte i Sverige hamnar i skymundan när fokus sätts på småbolag och nedmonteringen av Astrazeneca. Men de spelar en viktig r...

Forskningsinstitutet ska bli världsbäst

Unika analyser, personal med spetskompetens och kraftigt ökad kapa- citet – miljonsatsningarna på det nya Scilifelab gör labbet till en spelare i världsklass.

Medicin hett för fundraising

– området det mest populära hos privata finansiärer.